Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Sakakura, Kazunori Hasegawa, Koji Miyagawa, S. Nakashima, T. Yoshikawa, S. Kin, Y. Nakase, S. Yazumi, H. Yamagishi, T. Okanoue, T. Chiba, A. Hagiwara (2005)
Possible Involvement of RUNX3 Silencing in the Peritoneal Metastases of Gastric CancersClinical Cancer Research, 11
(BrizardAGardaisJHkmatologieL Heterogeneity of t(1; 19) (q2 3;pl3) acute leukaemias. Brit J Hematol 1995;89:516–26.)
BrizardAGardaisJHkmatologieL Heterogeneity of t(1; 19) (q2 3;pl3) acute leukaemias. Brit J Hematol 1995;89:516–26.BrizardAGardaisJHkmatologieL Heterogeneity of t(1; 19) (q2 3;pl3) acute leukaemias. Brit J Hematol 1995;89:516–26., BrizardAGardaisJHkmatologieL Heterogeneity of t(1; 19) (q2 3;pl3) acute leukaemias. Brit J Hematol 1995;89:516–26.
(LaveyRSEbyNLProsnitzLR Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer. Cancer 1981;66:874–81.)
LaveyRSEbyNLProsnitzLR Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer. Cancer 1981;66:874–81.LaveyRSEbyNLProsnitzLR Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer. Cancer 1981;66:874–81., LaveyRSEbyNLProsnitzLR Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer. Cancer 1981;66:874–81.
(TefferiAVardimanJW Myelodysplastic syndromes. N Engl J Med 2009;361:1872–85.19890130)
TefferiAVardimanJW Myelodysplastic syndromes. N Engl J Med 2009;361:1872–85.19890130TefferiAVardimanJW Myelodysplastic syndromes. N Engl J Med 2009;361:1872–85.19890130, TefferiAVardimanJW Myelodysplastic syndromes. N Engl J Med 2009;361:1872–85.19890130
F. Otto, M. Stock, M. Fliegauf, P. Fenaux, C. Preudhomme, M. Lübbert (2003)
Absence of somatic mutations within the Runt domain of AML2/RUNX3 in acute myeloid leukaemiaLeukemia, 17
(BellamyWTRichterLSirjaniD Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 2001;97:1427–35.11222390)
BellamyWTRichterLSirjaniD Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 2001;97:1427–35.11222390BellamyWTRichterLSirjaniD Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 2001;97:1427–35.11222390, BellamyWTRichterLSirjaniD Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 2001;97:1427–35.11222390
(ShanafeltTDByrdJCLaplantB Response to chemoimmunotherapy in patients with CLL. Brit J Hematol 2010;146:660–4.)
ShanafeltTDByrdJCLaplantB Response to chemoimmunotherapy in patients with CLL. Brit J Hematol 2010;146:660–4.ShanafeltTDByrdJCLaplantB Response to chemoimmunotherapy in patients with CLL. Brit J Hematol 2010;146:660–4., ShanafeltTDByrdJCLaplantB Response to chemoimmunotherapy in patients with CLL. Brit J Hematol 2010;146:660–4.
(DmKEgVTheVE Absence of somatic mutations within the Runt domain of AML2 /RUNX3 in acute myeloid leukaemia SOCS-1 gene methylation is frequent but does not appear to have prognostic value in patients with multiple myeloma. Leukemia 2003;17:1677–8.12886262)
DmKEgVTheVE Absence of somatic mutations within the Runt domain of AML2 /RUNX3 in acute myeloid leukaemia SOCS-1 gene methylation is frequent but does not appear to have prognostic value in patients with multiple myeloma. Leukemia 2003;17:1677–8.12886262DmKEgVTheVE Absence of somatic mutations within the Runt domain of AML2 /RUNX3 in acute myeloid leukaemia SOCS-1 gene methylation is frequent but does not appear to have prognostic value in patients with multiple myeloma. Leukemia 2003;17:1677–8.12886262, DmKEgVTheVE Absence of somatic mutations within the Runt domain of AML2 /RUNX3 in acute myeloid leukaemia SOCS-1 gene methylation is frequent but does not appear to have prognostic value in patients with multiple myeloma. Leukemia 2003;17:1677–8.12886262
Nahoko Nishimoto, M. Nakagawa, Andre Olsson (2013)
Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells.The Journal of clinical investigation, 123 9
Tohru Takahashi, Y. Kazama, H. Shimizu, M. Yoshimoto, M. Tsujisaki, S. Aoki, K. Imai (2001)
Myelodysplastic Syndrome Progresses Rapidly Into Erythroleukemia Associated With Synchronous Double Cancers of the Stomach and the Papilla of VaterInternational Journal of Hematology, 74
(HahmKLeeKMKimYB Conditional loss of TGF- signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment Pharmacol Ther 2003;16:115–27.)
HahmKLeeKMKimYB Conditional loss of TGF- signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment Pharmacol Ther 2003;16:115–27.HahmKLeeKMKimYB Conditional loss of TGF- signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment Pharmacol Ther 2003;16:115–27., HahmKLeeKMKimYB Conditional loss of TGF- signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment Pharmacol Ther 2003;16:115–27.
(KohlmannAGrossmannVKleinH-U Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010;28:3858–65.20644105)
KohlmannAGrossmannVKleinH-U Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010;28:3858–65.20644105KohlmannAGrossmannVKleinH-U Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010;28:3858–65.20644105, KohlmannAGrossmannVKleinH-U Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010;28:3858–65.20644105
D. Piestrzeniewicz-Ulanska, M. Bryś, A. Semczuk, J. Jakowicki, W. Krajewska (2002)
Expression of TGF-beta type I and II receptors in normal and cancerous human endometrium.Cancer letters, 186 2
Jian Wu, X. Pi, Z. Ye (2017)
Pre-B acute lymphoblastic leukemia with t(1;19) in an adult initially presenting as hematuria and bilateral renal enlargement: a case report and literature reviewClinical Nephrology. Case Studies, 5
(WeiYXiaoYMingZ Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T Cells in tumors of patients with hepatocellular carcinoma. Digestion 2009;79:169–76.19329856)
WeiYXiaoYMingZ Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T Cells in tumors of patients with hepatocellular carcinoma. Digestion 2009;79:169–76.19329856WeiYXiaoYMingZ Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T Cells in tumors of patients with hepatocellular carcinoma. Digestion 2009;79:169–76.19329856, WeiYXiaoYMingZ Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T Cells in tumors of patients with hepatocellular carcinoma. Digestion 2009;79:169–76.19329856
W. Bellamy, L. Richter, Davuud Sirjani, Concepcion Roxas, B. Glinsmann-Gibson, Y. Frutiger, T. Grogan, A. List (2001)
Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.Blood, 97 5
(EunJooLEun HuiSByung-WookK Endoscopic submucosal dissection for early gastric cancer in a patient with myelodysplastic syndrome. Korean J Gastroenterol 2015;65:173–6.25797381)
EunJooLEun HuiSByung-WookK Endoscopic submucosal dissection for early gastric cancer in a patient with myelodysplastic syndrome. Korean J Gastroenterol 2015;65:173–6.25797381EunJooLEun HuiSByung-WookK Endoscopic submucosal dissection for early gastric cancer in a patient with myelodysplastic syndrome. Korean J Gastroenterol 2015;65:173–6.25797381, EunJooLEun HuiSByung-WookK Endoscopic submucosal dissection for early gastric cancer in a patient with myelodysplastic syndrome. Korean J Gastroenterol 2015;65:173–6.25797381
(SakakuraCHagiwaraAMiyagawaK Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer 2005;113:221–8.15386419)
SakakuraCHagiwaraAMiyagawaK Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer 2005;113:221–8.15386419SakakuraCHagiwaraAMiyagawaK Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer 2005;113:221–8.15386419, SakakuraCHagiwaraAMiyagawaK Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer 2005;113:221–8.15386419
Du Meng, Yan-lan Chai, Yinghua He, Hongliang Hu, Rui Liu, Zi Liu (2014)
Cervical carcinoma following myelodysplastic syndrome: A case reportOncology Letters, 8
(Piestrzeniewicz-ulanskaDBrysMSemczukA Expression of TGF- type I and II receptors in normal and cancerous human endometrium. Cancer Lett 2003;186:231–9.)
Piestrzeniewicz-ulanskaDBrysMSemczukA Expression of TGF- type I and II receptors in normal and cancerous human endometrium. Cancer Lett 2003;186:231–9.Piestrzeniewicz-ulanskaDBrysMSemczukA Expression of TGF- type I and II receptors in normal and cancerous human endometrium. Cancer Lett 2003;186:231–9., Piestrzeniewicz-ulanskaDBrysMSemczukA Expression of TGF- type I and II receptors in normal and cancerous human endometrium. Cancer Lett 2003;186:231–9.
A. Tefferi, J. Vardiman (2009)
Myelodysplastic syndromes.The New England journal of medicine, 361 19
(HainsworthJHeimWBerlinJ Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–42.15175435)
HainsworthJHeimWBerlinJ Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–42.15175435HainsworthJHeimWBerlinJ Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–42.15175435, HainsworthJHeimWBerlinJ Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–42.15175435
(SandlerAGrayRPerryMC Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355:2542–50.17167137)
SandlerAGrayRPerryMC Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355:2542–50.17167137SandlerAGrayRPerryMC Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355:2542–50.17167137, SandlerAGrayRPerryMC Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355:2542–50.17167137
Ya-Wei Gao, Yu Chen, Zhi Wang, Jun Jin, Xin Li, Le-du Zhou, Zhi Huo, J. Zhou, Weisan Chen (2009)
Increased Expression of Cyclooxygenase-2 and Increased Infiltration of Regulatory T Cells in Tumors of Patients with Hepatocellular CarcinomaDigestion, 79
C. Pui, W. Carroll, S. Meshinchi, R. Arceci (2011)
Biology, risk stratification, and therapy of pediatric acute leukemias: an update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 5
E. Lim, Eun Sim, B. Kim, Jong Kim, J. Kim, J. Ji, Hwang Choi (2015)
Endoscopic submucosal dissection for early gastric cancer in a patient with myelodysplastic syndrome.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 65 3
Z. Iqbal (2014)
Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region.Asian Pacific journal of cancer prevention : APJCP, 15 8
(SakakuraCHasegawaKMiyagawaK Human cancer biology possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin Cancer Res 2005;11:6479–89.16166423)
SakakuraCHasegawaKMiyagawaK Human cancer biology possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin Cancer Res 2005;11:6479–89.16166423SakakuraCHasegawaKMiyagawaK Human cancer biology possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin Cancer Res 2005;11:6479–89.16166423, SakakuraCHasegawaKMiyagawaK Human cancer biology possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin Cancer Res 2005;11:6479–89.16166423
A. Pellagatti, Noor Esoof, F. Watkins, C. Langford, D. Vetrie, L. Campbell, C. Fidler, J. Cavenagh, H. Eagleton, P. Gordon, B. Woodcock, Beena Pushkaran, M. Kwan, J. Wainscoat, J. Boultwood (2004)
Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technologyBritish Journal of Haematology, 125
(HungerBSPGaliliNCarrollAJ The t(1;19)(q23;p13) results in consistent fusion of E2A and PBXl coding sequences in acute lymphoblastic leukemias. Blood 1991;77:687–94.1671560)
HungerBSPGaliliNCarrollAJ The t(1;19)(q23;p13) results in consistent fusion of E2A and PBXl coding sequences in acute lymphoblastic leukemias. Blood 1991;77:687–94.1671560HungerBSPGaliliNCarrollAJ The t(1;19)(q23;p13) results in consistent fusion of E2A and PBXl coding sequences in acute lymphoblastic leukemias. Blood 1991;77:687–94.1671560, HungerBSPGaliliNCarrollAJ The t(1;19)(q23;p13) results in consistent fusion of E2A and PBXl coding sequences in acute lymphoblastic leukemias. Blood 1991;77:687–94.1671560
Powers (2007)
Polymorphisms in TGF and TNF α are associated with the myelodysplastic syndrome phenotypeArch Pathol Lab Med, 131
(LiuJYuHYuJ Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasis. Med Oncol 2005;22:389–97.16260857)
LiuJYuHYuJ Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasis. Med Oncol 2005;22:389–97.16260857LiuJYuHYuJ Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasis. Med Oncol 2005;22:389–97.16260857, LiuJYuHYuJ Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasis. Med Oncol 2005;22:389–97.16260857
(ArberDAOraziAHasserjianR The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2018;127:2391–406.)
ArberDAOraziAHasserjianR The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2018;127:2391–406.ArberDAOraziAHasserjianR The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2018;127:2391–406., ArberDAOraziAHasserjianR The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2018;127:2391–406.
(PellagattiAEsoofNLangfordCF Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Brit J Hematol 2004;125:576–83.)
PellagattiAEsoofNLangfordCF Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Brit J Hematol 2004;125:576–83.PellagattiAEsoofNLangfordCF Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Brit J Hematol 2004;125:576–83., PellagattiAEsoofNLangfordCF Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Brit J Hematol 2004;125:576–83.
Jin Liu, Hong-gang Yu, Jie-ping Yu, Xiao-ling Wang, Xiao-dong Zhou, He-sheng Luo (2005)
Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasisMedical Oncology, 22
Bhagat (2018)
miR-21 mediates hematopoietic suppression in MDS by activating TGF- signalingBlood, 121
(PuiCCarrollWLMeshinchiS Risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011;29:551–65.21220611)
PuiCCarrollWLMeshinchiS Risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011;29:551–65.21220611PuiCCarrollWLMeshinchiS Risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011;29:551–65.21220611, PuiCCarrollWLMeshinchiS Risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011;29:551–65.21220611
(LiuGXiangTWuQ Long noncoding RNA H19-derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells. Oncol Res 2016;23:99–107.26931432)
LiuGXiangTWuQ Long noncoding RNA H19-derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells. Oncol Res 2016;23:99–107.26931432LiuGXiangTWuQ Long noncoding RNA H19-derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells. Oncol Res 2016;23:99–107.26931432, LiuGXiangTWuQ Long noncoding RNA H19-derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells. Oncol Res 2016;23:99–107.26931432
C. Sakakura, A. Hagiwara, Koji Miyagawa, S. Nakashima, T. Yoshikawa, S. Kin, Y. Nakase, Kosei Ito, H. Yamagishi, S. Yazumi, T. Chiba, Yoshiaki Ito (2005)
Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancerInternational Journal of Cancer, 113
(IchimCV Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy. J Transl Med 2005;13:1–3.)
IchimCV Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy. J Transl Med 2005;13:1–3.IchimCV Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy. J Transl Med 2005;13:1–3., IchimCV Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy. J Transl Med 2005;13:1–3.
T. Bhagat, L. Zhou, L. Sokol, R. Kessel, G. Caceres, Krishna Gundabolu, R. Tamari, Shanisha Gordon, I. Mantzaris, T. Jodlowski, Yiting Yu, Xiaohong Jing, R. Polineni, K. Bhatia, A. Pellagatti, J. Boultwood, S. Kambhampati, U. Steidl, C. Stein, W. Ju, Gang Liu, P. Kenny, A. List, M. Bitzer, A. Verma (2013)
miR-21 mediates hematopoietic suppression in MDS by activating TGF-b signaling
(BhagatTDZhouLSokolL miR-21 mediates hematopoietic suppression in MDS by activating TGF- signaling. Blood 2018;121:2875–82.)
BhagatTDZhouLSokolL miR-21 mediates hematopoietic suppression in MDS by activating TGF- signaling. Blood 2018;121:2875–82.BhagatTDZhouLSokolL miR-21 mediates hematopoietic suppression in MDS by activating TGF- signaling. Blood 2018;121:2875–82., BhagatTDZhouLSokolL miR-21 mediates hematopoietic suppression in MDS by activating TGF- signaling. Blood 2018;121:2875–82.
Dm (2003)
Absence of somatic mutations within the Runt domain of AML2 /RUNX3 in acute myeloid leukaemia SOCS-1 gene methylation is frequent but does not appear to have prognostic value in patients with multiple myelomaLeukemia, 17
(IqbalZ Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region. Asian Pac J Cancer 2014;15:3541–6.)
IqbalZ Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region. Asian Pac J Cancer 2014;15:3541–6.IqbalZ Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region. Asian Pac J Cancer 2014;15:3541–6., IqbalZ Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region. Asian Pac J Cancer 2014;15:3541–6.
A. Roberts, M. Sporn, R. Assoian, J. Smith, N. Roche, L. Wakefield, U. Heine, L. Liotta, V. Falanga, J. Kehrl (1986)
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.Proceedings of the National Academy of Sciences of the United States of America, 83 12
C. Ichim (2005)
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapyJournal of Translational Medicine, 3
A. Kohlmann, V. Grossmann, H. Klein, S. Schindela, T. Weiss, B. Kazak, F. Dicker, S. Schnittger, M. Dugas, W. Kern, C. Haferlach, T. Haferlach (2010)
Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 24
D. Arber, A. Orazi, R. Hasserjian, J. Thiele, M. Borowitz, M. Beau, C. Bloomfield, M. Cazzola, J. Vardiman (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.Blood, 127 20
Gao Liu, Tian Xiang, Quanfeng Wu, Wei-xing Wang (2016)
Long Noncoding RNA H19-Derived miR-675 Enhances Proliferation and Invasion via RUNX1 in Gastric Cancer CellsOncology Research, 23
S. Hunger, N. Galili, A. Carroll, W. Crist, M. Link, Michael Cleary (1991)
The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.Blood, 77 4
(TakahashiTKazamaYShimizuH Case report myelodysplastic syndrome progresses rapidly into erythroleukemia associated with synchronous double cancers of the stomach and the papilla of vater. Int J Hematol 2001;1708:64–9.)
TakahashiTKazamaYShimizuH Case report myelodysplastic syndrome progresses rapidly into erythroleukemia associated with synchronous double cancers of the stomach and the papilla of vater. Int J Hematol 2001;1708:64–9.TakahashiTKazamaYShimizuH Case report myelodysplastic syndrome progresses rapidly into erythroleukemia associated with synchronous double cancers of the stomach and the papilla of vater. Int J Hematol 2001;1708:64–9., TakahashiTKazamaYShimizuH Case report myelodysplastic syndrome progresses rapidly into erythroleukemia associated with synchronous double cancers of the stomach and the papilla of vater. Int J Hematol 2001;1708:64–9.
A. Sandler, R. Gray, M. Perry, J. Brahmer, J. Schiller, A. Dowlati, R. Lilenbaum, David Johnson (2006)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.The New England journal of medicine, 355 24
K. Hahm, K. Lee, Y. Kim, Hong Ws, Lee Wh, S. Han, M. Kim, A. Bo, Oh Ty, Lee Mh, J. Green, Seong Kim (2002)
Conditional loss of TGF‐β signalling leads to increased susceptibility to gastrointestinal carcinogenesis in miceAlimentary Pharmacology & Therapeutics, 16
T. Shanafelt, J. Byrd, B. Laplant, C. Zent, T. Call, C. Secreto, M. Grever, T. Lin, N. Kay (2009)
Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemiaBritish Journal of Haematology, 146
(RobertsABSpornMBAssoianRK Transforming growth factor type: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 1986;83:4167–71.2424019)
RobertsABSpornMBAssoianRK Transforming growth factor type: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 1986;83:4167–71.2424019RobertsABSpornMBAssoianRK Transforming growth factor type: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 1986;83:4167–71.2424019, RobertsABSpornMBAssoianRK Transforming growth factor type: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 1986;83:4167–71.2424019
X. Troussard, R. Rimokh, F. Valensi, D. Leboeuf, Odile Fennbtbau, A. Guitard, A. Manel, F. Schillinger, Chantal Leglise, A. Brizard, J. Gardais, M. Lessard, G. Flandrin, E. Macintyre (1995)
Heterogeneity of t(1;19)(q23;p13) acute leukaemiasBritish Journal of Haematology, 89
R. Lavey, N. Eby, L. Prosnitz (1990)
Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancerCancer, 66
(PowersMPNishinoHLuoY Polymorphisms in TGF and TNF α are associated with the myelodysplastic syndrome phenotype. Arch Pathol Lab Med 2007;131:1789–93.18081437)
PowersMPNishinoHLuoY Polymorphisms in TGF and TNF α are associated with the myelodysplastic syndrome phenotype. Arch Pathol Lab Med 2007;131:1789–93.18081437PowersMPNishinoHLuoY Polymorphisms in TGF and TNF α are associated with the myelodysplastic syndrome phenotype. Arch Pathol Lab Med 2007;131:1789–93.18081437, PowersMPNishinoHLuoY Polymorphisms in TGF and TNF α are associated with the myelodysplastic syndrome phenotype. Arch Pathol Lab Med 2007;131:1789–93.18081437
M. Powers, H. Nishino, Yamin Luo, A. Raza, A. Vanguri, L. Rice, Y. Zu, C. Chang (2007)
Polymorphisms in TGFβ and TNFα are associated with the myelodysplastic syndrome phenotypeArchives of Pathology & Laboratory Medicine, 131
(GoyamaSSchiblerJCunninghamL Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J Clin Invest 2013;123:3876–88.23979164)
GoyamaSSchiblerJCunninghamL Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J Clin Invest 2013;123:3876–88.23979164GoyamaSSchiblerJCunninghamL Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J Clin Invest 2013;123:3876–88.23979164, GoyamaSSchiblerJCunninghamL Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J Clin Invest 2013;123:3876–88.23979164
(WuJPiXYeZ Pre-B acute lymphoblastic leukemia with t (1; 19) in an adult initially presenting as hematuria and bilateral renal enlargement: a case report and literature review. Clin Nephrol Case Stud 2017;5:60–5.29043149)
WuJPiXYeZ Pre-B acute lymphoblastic leukemia with t (1; 19) in an adult initially presenting as hematuria and bilateral renal enlargement: a case report and literature review. Clin Nephrol Case Stud 2017;5:60–5.29043149WuJPiXYeZ Pre-B acute lymphoblastic leukemia with t (1; 19) in an adult initially presenting as hematuria and bilateral renal enlargement: a case report and literature review. Clin Nephrol Case Stud 2017;5:60–5.29043149, WuJPiXYeZ Pre-B acute lymphoblastic leukemia with t (1; 19) in an adult initially presenting as hematuria and bilateral renal enlargement: a case report and literature review. Clin Nephrol Case Stud 2017;5:60–5.29043149
(MengDChaiYHeY Cervical carcinoma following myelodysplastic syndrome: a case report. Oncol Lett 2014;8:82–4.24959223)
MengDChaiYHeY Cervical carcinoma following myelodysplastic syndrome: a case report. Oncol Lett 2014;8:82–4.24959223MengDChaiYHeY Cervical carcinoma following myelodysplastic syndrome: a case report. Oncol Lett 2014;8:82–4.24959223, MengDChaiYHeY Cervical carcinoma following myelodysplastic syndrome: a case report. Oncol Lett 2014;8:82–4.24959223
H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, E. Holmgren, N. Ferrara, G. Fyfe, B. Rogers, R. Ross, F. Kabbinavar (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.The New England journal of medicine, 350 23
AbstractRationale:Myelodysplastic syndrome (MDS) is a heterogeneous malignant hematologic disease with median overall survival ranging from six months to more than ten years. Solid tumor rarely occurs in combination with MDS and the underlying pathogenesis and prognostic significance still remain controversial.Patient concerns:Here we report a relative low risk myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia (MDS-RCMD) patient, with a rare t(1; 19)chromosome translocation. This patient also suffered from gastric carcinoma.Diagnoses:Gastric carcinoma, Myelodysplastic syndrome with t (1; 19) chromosome translocation.Interventions:This patient received radical operation for gastric carcinoma and erythropoietin infusion.Outcomes:The patient took follow up visits every 2 to 3 months in past years and now he is in stable disease without further treatment.Lessons:We reviewed the mechanism of MDS complicated by solid tumor and concluded the potential mechanisms of this patient. The interactions between potential factors may play a role in oncogenesis which, however, need an in-depth study of its operating mechanism.
Medicine – Pubmed Central
Published: Jul 27, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.